|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,616.16 |
3.46% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$62,103.45 |
3.04% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$59,206.09 |
2.90% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$54,189.20 |
2.66% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$51,912.90 |
2.54% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$48,383.17 |
2.37% |
| Waters Corporation |
WAT |
941848103 |
148 |
$47,858.75 |
2.35% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$46,812.89 |
2.29% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$45,151.08 |
2.21% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$45,183.12 |
2.21% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$45,091.04 |
2.21% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,198.56 |
2.17% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$44,245.41 |
2.17% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,858.02 |
2.15% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$43,405.56 |
2.13% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$42,852.24 |
2.10% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$42,407.23 |
2.08% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$42,189.45 |
2.07% |
| Steris Plc |
STE |
G8473T100 |
169 |
$41,971.15 |
2.06% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$41,878.26 |
2.05% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$41,586.82 |
2.04% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$41,238.30 |
2.02% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$40,945.43 |
2.01% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$40,893.93 |
2.00% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$40,605.45 |
1.99% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$39,899.45 |
1.96% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$39,313.77 |
1.93% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$38,366.32 |
1.88% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$38,117.83 |
1.87% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$38,228.18 |
1.87% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$38,074.48 |
1.87% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$37,891.63 |
1.86% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$37,640.46 |
1.84% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$37,124.85 |
1.82% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$36,736.52 |
1.80% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$35,958.43 |
1.76% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$35,921.40 |
1.76% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$35,340.43 |
1.73% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$35,217.66 |
1.73% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$34,652.50 |
1.70% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$34,379.04 |
1.68% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$33,916.68 |
1.66% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$33,043.58 |
1.62% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$32,395.20 |
1.59% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$31,623.27 |
1.55% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$31,237.14 |
1.53% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$30,827.98 |
1.51% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$30,305.96 |
1.49% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$27,558.70 |
1.35% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$25,639.32 |
1.26% |
| US Dollar |
$USD |
|
2,196 |
$2,195.53 |
0.11% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|